Comparison of the AS52/XPRT and the CHO/HPRT assays: evaluation of 6 drug candidates.
The purpose of this paper is to compare the result of testing a diverse group of chemicals in the CHO/HPRT and AS52/XPRT mutation assays. The AS52/XPRT system was as sensitive as the more widely used CHO/HPRT system in the case of the antitumor agents, and gave qualitatively similar results in all cases. On the basis of this and other experiments (Aaron et al., 1989) it appears that the AS52/XPRT system may be most useful in addressing mechanistic questions in mutagenesis. We recommend that the AS52/XPRT assay be used as the mammalian cell test system of choice in batteries used for identifying mutagens and genotoxic carcinogens.
Aaron
C S
CS
Upjohn Company, Kalamazoo, MI.
Stankowski
L F
LF
D000818:Animals; D002460:Cell Line; D002470:Cell Survival; D002872:Chromosome Deletion; D006224:Cricetinae; D003412:Cricetulus; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics*; D009152:Mutagenicity Tests; D009153:Mutagens; D010430:Pentosyltransferases / Q000235:genetics*
D009153:Mutagens; D010430:Pentosyltransferases; C024827:xanthine phosphoribosyltransferase; D007041:Hypoxanthine Phosphoribosyltransferase